EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular Mechanisms of APOL1-Associated Kidney Disease

Charlotte Delrue, Reinhart Speeckaert iD, Marijn M Speeckaert iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27062863 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Charlotte Delrue und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium. Hauptthemen laut MEDLINE: Apolipoprotein L1, Kidney Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The discovery of apolipoprotein L1 (APOL1) risk polymorphisms has significantly changed our knowledge of kidney disease susceptibility and development in African American populations. Several non-diabetic kidney disorders, such as focal segmental glomerulosclerosis (FSGS), collapsing glomerulopathy, HIV-associated nephropathy (HIVAN), and accelerated chronic kidney disease (CKD) development, are significantly more likely to occur in people with two coding variations, G1 and G2. The significance of context-dependent pathogenic processes is highlighted by the poor penetrance and remarkable phenotypic variety of APOL1-associated kidney disease, despite its substantial impact. This review synthesizes current knowledge of APOL1 biology through a molecular framework, emphasizing gain-of-toxic-function effects of risk variants in podocytes, dysregulated ion fluxes, mitochondrial dysfunction, impaired proteostasis, and activation of innate immune and inflammatory signaling pathways. We describe how the well-recognized “second-hit” paradigm has a biological basis, driven by strong inducibility by interferons and immunological activation, as well as strict basal regulation of APOL1 expression. Lastly, we explore future approaches to precision nephrology and highlight translational advancements, such as APOL1 gene-silencing techniques. This review provides a mechanistic roadmap for translating APOL1 biology into targeted therapeutic strategies by integrating genetics, cell biology, immunology, and systems-level approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein L1Kidney DiseasesHumansAnimalsPodocytesGenetic Predisposition to DiseaseSignal TransductionMitochondria

Stichwörter der Autor:innen

APOL1chronic kidney diseasegene–environment interactioninterferon signalingmitochondrial dysfunctionpodocytesprecision nephrologyproteostasis

Substanzen

Apolipoprotein L1APOL1 protein, human

Autor:innen und Institutionen

  • Department of Nephrology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Department of Dermatology, Ghent University Hospital, 9000 Ghent, Belgium.
  • Research Foundation-Flanders (FWO), 1000 Brussels, Belgium.

ORCID-Profile: Reinhart Speeckaert, Marijn M Speeckaert

Zitieren

APA

Delrue, C., Speeckaert, R., & Speeckaert, M. M. (2026). Molecular Mechanisms of APOL1-Associated Kidney Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27062863

Vancouver

Delrue C, Speeckaert R, Speeckaert MM. Molecular Mechanisms of APOL1-Associated Kidney Disease. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27062863

BibTeX
@article{Delrue2026,
  author = {Delrue, Charlotte and Speeckaert, Reinhart and Speeckaert, Marijn M},
  title = {Molecular Mechanisms of APOL1-Associated Kidney Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27062863}
}
Kostenlos starten →